FloDynamix LLC of Rohnert Park, CA has introduced Gumlast® L7509 perfluoroelastomer for contamination sensitive Semicon processes. Gumlast L7509 is crystal clear, un-filled perfluoro with extremely low out-gassing properties. It is ideal for ALD and MOCVD processes where moisture out-gassing from sealing components interferes with film stochiometry and uniformity. Gumlast L7509 is manufactured in The United States in a cleanroom environment. In addition, Gumlast L7509 exhibits very low sticking properties which has been a key drawback of many translucent perfluoros in the market. For further information, please contact Fred Pourmirzaie at fpour@flodynamix.com.
February 2009
NuGenTec to Exhibit it's FloDynamix™ product line at the
NCCAVS 30th Annual Vacuum Equipment Exhibition, at the
WYNDHAM SAN JOSE, 1350 N. First Street, San Jose, CA 95112,
Wednesday, February 11, 2009,
12:00 to 6:00 PM. Visit us at Booth #10. Attendance to this Exhibit is Free for all Visitors.
February 2009
Bill Schouten joins NuGenTec to head up the Building Materials Division. Bill brings over 30 years of experience with him and we are excited to have him on board.
December 2008
NuGen's Government Contracting group secured a number of 5 year contracts with the GSA (US General Services Administration) and the US Federal Acquisition Service (FAS). These contracts are valued at over $5,000,000 over the next 5 years.
NuGenTec Launches Clean-N-Clear a safe non-toxic, biodegradable, non-hazardous BioBased product. With USDA BioPreferred approval.
September 2006
NuGenTec Partners with Global Cleaning Technologies (GCT) for Sales, Service and Tech Support in California and Arizona
July 2005
NuGenTec Launches NuKoat RP1 copper and galvanic corrosion protection
additive for water based chemical process tanks in electronics markets:
Heads/wafers. Prior to 2006 RP1 was exclusively formulated and sold to
IBM (now HGST, Hitachi Global Storage Technologies)
June 2005
NuGeneration Technologies Expands production from California to Texas and New Jersey.
Thalidomide binding protein revealed Scientists in Japan believe they have revealed one of the key molecular targets that binds to the drug thalidomide to cause birth defects
Shape-shifting polymers Polymer can reversibly take on a range of different shapes in response to changes in temperature
China slows R&D funding growth After a hefty 30 per cent increase in science funding last year, China’s proposed budget scales back research funding growth for 2010
Nanotube ‘fuse’ generates power Coating nanotubes with fuel allows them to convert an exothermic reaction into electricity, thereby opening up new avenues in energy research
Soapy solution for scratched surfaces Chinese scientists have developed a superhydrophobic coating that can be repaired by treating the surface with a potassium stearate solution
Fund science or risk economic downfall Researchers and former science ministers warn UK government of ‘decades of slow economic decline’ unless science receives heavy investment
Ultrasensitive DNA detection A lipase-based sensor detects tiny quantities of DNA and could be used to test for bacteria that spoils beer.
Green by design carpet tiles Switchable adhesives made from renewable resources make carpet tiles more environmentally friendly, say UK scientists
Coming clean on emissions outsourcing Study details proportion of developed countries carbon dioxide emissions that are ‘outsourced’ to emerging economies
Novel foams reduce fire risk Treating soft furnishings with toxic flame-retardants could be avoided in the future thanks to a new non-flammable polymer developed by US scientists
Solvated electron mystery solved Researchers directly measure binding energy of electrons in aqueous solution, finding that those in bulk solution behave differently to those on the surface
The Commercial Chemist Chemistry World gets down to business with our weekly round-up of money and molecules
EC approves first GM crop in a decade European Commission authorises cultivation of genetically modified potato Amflora, the first new GM crop approved in 12 years